-
Summit Therapeutics Inc. (NASDAQ:SMMT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Source: Buzz FX / 05 Jan 2025 05:51:13 America/Chicago
Summit Therapeutics Inc. (NASDAQ:SMMT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 5, 2025 Share Link copied to clipboard. Summit Therapeutics Inc.
Read more...